Brazil will suspend a $324-million contract for Covaxin from Bharat Biotech that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, even as the Indian drugmaker insisted that it has not received any advance payments.
from Times of India https://ift.tt/3h3oVS6
from Times of India https://ift.tt/3h3oVS6